KPV: The Anti-Inflammatory C-Terminal of alpha-MSH
Research Focus: KPV is a potent tripeptide that lacks the pigment-stimulating effects of MSH but retains its ability to shut down NF-kappaB signaling, making it a target for inflammatory bowel disease (IBD) research.
